Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT20161103030680N9
IRCT20161103030680N9
Completed
Phase 2

Evaluation of citalopram efficacy in prevention of migraine headaches

Shahed University0 sites226 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Shahed University
Enrollment
226
Status
Completed
Last Updated
8 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Age between 18 to 45\.
  • •Suffering from migraine headaches according to international headache society criteria(IHS).
  • •At least three attack of migraine in one month.
  • •History of migraine for at least six months.

Exclusion Criteria

  • •Suffering from another type of headaches such as Cluster,Tension,.... .
  • •History of Asthma, Renal and Heart failure, Depression, any allergic reaction to drugs used in study or similar drugs.
  • •Patients who already take drugs for treatment for migraine.
  • •History of using anti depressant, anti epileptics, Analgesics, Corticosteroids, Opium, Monoamine Oxidase, and Non steroidal anti inflammatory agents for other reasons.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 2
A comparative study of the effect of citalopram in the prevention of delirium in intubated patients without brain damage in Labafinejad Hospital IC
IRCT20190215042716N6Shahid Beheshti University of Medical Sciences62
Recruiting
Phase 3
Effect of Citalopram on Endometriosis
IRCT20180211038692N2Tehran University of Medical Sciences80
Active, not recruiting
Phase 2
Evaluating treatment efficacy of citalopram, symbiotic, and mebeverine for children with functional abdominal pain.
ACTRN12613000158763Isfahan University of medical silences200
Active, not recruiting
Phase 1
A trial to investigate the effect of citalopram for the treatment of typical reflux symptoms
EUCTR2017-004174-34-BETargid, KU Leuven100
Completed
Phase 2
Comparison of the efficacy of citalopram and compound of Asperugo procumbens and foeniculum vulgare in treatment of menopausal disordersMenopausal and female climacteric states.Symptoms such as flushing, sleeplessness, headache, lack of concentration, associated with menopause
IRCT2013072714174N1Vice chancellor for research, Tehran University of Medical Sciences60